These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 15222015)

  • 1. Immunosuppressory activity of ubiquitin fragments containing retro-RGD sequence.
    Szewczuk Z; Stefanowicz P; Wilczyński A; Staszewska A; Siemion IZ; Zimecki M; Wieczorek Z
    Biopolymers; 2004 Aug; 74(5):352-62. PubMed ID: 15222015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressory activity of the cyclodimeric peptide with RGD-sequences.
    Szewczuk Z; Buczek P; Stefanowicz P; Krajewski K; Wieczorek Z; Siemion IZ
    Acta Biochim Pol; 2001; 48(1):121-30. PubMed ID: 11440161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel immunosuppressory peptide originating from the ubiquitin sequence.
    Pasikowski P; Goździewicz T; Stefanowicz P; Artym J; Zimecki M; Szewczuk Z
    Peptides; 2011 Dec; 32(12):2418-27. PubMed ID: 22008734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunosuppressive activity and solution structures of ubiquitin fragments.
    Jaremko L; Jaremko M; Pasikowski P; Cebrat M; Stefanowicz P; Lisowski M; Artym J; Zimecki M; Zhukov I; Szewczuk Z
    Biopolymers; 2009 Jun; 91(6):423-31. PubMed ID: 19213045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimeric analogs of immunosuppressive decapeptide fragment of ubiquitin.
    Kluczyk A; Cydzik M; Biernat M; Bąchor R; Pasikowski P; Stefanowicz P; Artym J; Zimecki M; Szewczuk Z
    J Pept Sci; 2012 Jul; 18(7):456-65. PubMed ID: 22628071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New conformationally restricted analog of the immunosuppressory mini-domain of HLA-DQ and its biological properties.
    Szewczuk Z; Wilczyński A; Dyba M; Petry I; Siemion IZ; Wieczorek Z
    Peptides; 2000 Dec; 21(12):1849-58. PubMed ID: 11150645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimerization of the immunosuppressive peptide fragment of HLA-DR molecule enhances its potency.
    Szewczuk Z; Biernat M; Dyba M; Zimecki M
    Peptides; 2004 Feb; 25(2):207-15. PubMed ID: 15063002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressory mini-regions of HLA-DP and HLA-DR.
    Szewczuk Z; Wilczyński A; Stefanowicz P; Fedorowicz W; Siemion IZ; Wieczorek Z
    Mol Immunol; 1999 Jun; 36(8):525-33. PubMed ID: 10475607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive activity of alanine analogs of cyclolinopeptide A.
    Wieczorek Z; Zimecki M; Pedyczak A; Lisowski M; Siemion IZ
    Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):291-6. PubMed ID: 8010868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunosuppressory and adhesive miniregion of the human major histocompatibility protein, human leukocyte antigen DQ.
    Szewczuk Z; Stefanowicz P; Wilczyński A; Siemion IZ; Cierniewski CS; Kralisz U; Wieczorek Z
    Biopolymers; 1996; 40(5):571-83. PubMed ID: 9062075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive activity of some peptides related to cycloamanide A (CyA A) and to the active fragment of a peptide immunomodulator from ovine colostrum.
    Bolewska-Pedyczak E; Wieczorek Z; Zimecki M; Siemion IZ
    Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):297-301. PubMed ID: 8010869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive activity of analogs of tripeptide Lys-Arg-Pro with D-amino acid residues.
    Siemion IZ; Kluczyk A; Słoń JJ; Zimecki M; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1994; 42(3):205-7. PubMed ID: 7487354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
    Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
    J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunosuppressive mini-domain of human lactoferrin.
    Siemion IZ; Sloń J; Wieczorek Z
    J Pept Sci; 1995; 1(5):295-302. PubMed ID: 9223008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological activities of cyclic lactam peptide analogues of dynorphine A(1-11)-NH2.
    Lung FD; Collins N; Stropova D; Davis P; Yamamura HI; Porreca F; Hruby VJ
    J Med Chem; 1996 Mar; 39(5):1136-41. PubMed ID: 8676350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further investigations on thymopentin-like fragments of HLA-DQ and their analogs.
    Szewczuk Z; Wieczorek Z; Stefanowicz P; Wilczyński A; Siemion IZ
    Arch Immunol Ther Exp (Warsz); 1997; 45(4):335-41. PubMed ID: 9523010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of a new bridged immunosuppressor.
    Szewczuk Z; Wilczyński A; Petry I; Siemion IZ; Wieczorek Z
    Acta Biochim Pol; 2001; 48(4):1147-50. PubMed ID: 11995982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constrained corticotropin-releasing factor (CRF) agonists and antagonists with i-(i+3) Glu-Xaa-DXbb-Lys bridges.
    Koerber SC; Gulyas J; Lahrichi SL; Corrigan A; Craig AG; Rivier C; Vale W; Rivier J
    J Med Chem; 1998 Dec; 41(25):5002-11. PubMed ID: 9836618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the guanidine group in the N-terminal fragment of PTH(1-11).
    Caporale A; Woznica I; Schievano E; Mammi S; Peggion E
    Amino Acids; 2010 Apr; 38(4):1269-75. PubMed ID: 19690796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrophilic peptides derived from the transframe region of Gag-Pol inhibit the HIV-1 protease.
    Louis JM; Dyda F; Nashed NT; Kimmel AR; Davies DR
    Biochemistry; 1998 Feb; 37(8):2105-10. PubMed ID: 9485357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.